Loading the player ...
  • Share:
  • Embed
  • URL
  • Email Facebook Twitter ShareThis

The Cost of Cancer Treatment: Genome Sequencing and Drugs (excerpt)

Physician-researcher Joseph Sparano, M.D., discusses the “holy grail” of genomics testing – the $1,000 genome screen. He tells Einstein’s Paul Moniz why it may be economical for future patients to consider getting tested. Dr. Sparano is associate director for clinical research at Albert Einstein Cancer Center and associate chairman of medical oncology at Montefiore Einstein Center for Cancer Care. Watch full interview. (October 16, 2012)

  • Related
  • Popular
  • Recent
  • Spotlights
  • Subscribe:
  • iTunes
  • YouTube